Glaucoma, Open-Angle clinical trials at UCSF
1 in progress, 1 open to new patients
Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
open to eligible people ages 18 years and up
This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.
San Francisco, California and other locations